Sbi Securities Co., Ltd. Prelude Therapeutics Inc Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 2,741 shares of PRLD stock, worth $3,206. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,741Holding current value
$3,206% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRLD
# of Institutions
70Shares Held
35.9MCall Options Held
500Put Options Held
300-
Orbimed Advisors LLC San Diego, CA10.9MShares$12.8 Million0.53% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$11.8 Million0.22% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.77MShares$4.41 Million0.14% of portfolio
-
Boxer Capital, LLC San Diego, CA1.71MShares$2 Million0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.1MShares$1.28 Million0.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $42.6M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...